UnicoCell Biomed Co., Ltd.

Research UnicoCell Biomed Co., Ltd. (6794.TW) on Bullrun: market cap TWD 4.43B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Ticker6794.TW
ExchangeTW
CountryTaiwan
SectorHealthcare
IndustryBiotechnology
CurrencyTWD
Market capTWD 4.43B
Financial periodQ2 2026
RevenueTWD 4.60M
Net income-TWD 25.03M
Free cash flow-TWD 16.31M
Gross margin61.1%

Valuation Snapshot

latest market cap is TWD 4.43B.

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-10-18	TWD 4.43B	n/a	n/a	0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 TWD.

About UnicoCell Biomed Co., Ltd.

UnicoCell Biomed Co., Ltd. engages in the research and development of stem cell drugs in Taiwan and Japan. The company develops ELIXCYTE for the treatment of knee osteoarthritis and chronic kidney disease. It also operates an allogeneic adipose stem cell bank. In addition, the company offers autologous stem cell therapy; conditioned medium; UnicoVial, a cryogenic vial for the storage of cell products and biological samples under ultra-low temperature;

Related stock research

Taiwan stocks Taiwan Healthcare stocks A-Z stock index

Other Healthcare stocks

Synbio Tech Inc. (1295.TWO) Sinphar Pharmaceutical Co.,Ltd. (1734.TW) Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762.TW) SYN-TECH Chem. & Pharm. Co., Ltd. (1777.TWO) Level Biotechnology Inc. (3118.TWO) GenMont Biotech Incorporation (3164.TW) Medigen Biotechnology Corp. (3176.TWO) Sagittarius Life Science Corp (3205.TWO) NeoCore Technology Co., Ltd. (4131.TWO) Abnova (Taiwan) Corporation (4133.TW) Adimmune Corporation (4142.TW) TaiMed Biologics Inc. (4147.TWO)

Frequently asked questions

What is UnicoCell Biomed Co., Ltd.'s market cap?

UnicoCell Biomed Co., Ltd.'s market capitalization is TWD 4.43B.